瘤微环境中的神经终端作为局部透止痛的目标
Pallavi Madhusudanan1, Chinnu Jerard1, Gayathri Raju1
1Amrita School of Nanosciences & Molecular Medicine, Amrita Institute of Medical Sciences & Research Center, Amrita Vishwa Vidyapeetham, Kochi, Kerala 682041, India.
Neuroscience research
|June 19, 2023
概括
针对神经终端的局部透止痛疗法对治疗癌症诱导的骨疼痛 (CIBP) 显示出有前途. 关键的止痛药有效地减少了老鼠模型中的疼痛,这表明了新的治疗策略.
科学领域:
- 在瘤学瘤学.
- 疼痛管理 疼痛管理
- 神经科学是一个神经科学.
背景情况:
- 对癌症疼痛的局部透止痛疗法尚未得到充分研究.
- 瘤微环境中的神经终端是潜在的疼痛目标.
研究的目的:
- 研究针对神经末端的局部止痛药对癌症诱导的骨疼痛 (CIBP) 的疗效.
- 评估三角阿片类受体激动剂 (DOPr),通道阻断剂和TRPV1对抗剂在CIBP管理中的作用.
主要方法:
- 使用MRMT1乳腺癌细胞建立了CIBP的老鼠模型.
- 在体外成像评估了对止痛药的感觉神经元反应.
- 行为测试量化了局部止痛药后的疼痛值.
主要成果:
- 在CIBP动物中,DOPr,通道和TRPV1在感觉神经元中表达.
- 针对DOPr,通道和TRPV1的局部止痛药显著降低了神经元活动.
- 周周注射一种DOPr激动剂和T型抗体缓解了瘤部位的过敏症.
结论:
- 瘤微环境中的神经终端是局部透止痛的可行目标.
- 准这些神经终端为缓解癌症疼痛提供了一个有希望的策略,特别是CIBP.
相关概念视频
The Tumor Microenvironment
6.7K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.7K
Local Anesthetics: Differential Sensitivity of Nerve Fibers
879
Local anesthetics (LAs) block the sodium channels of nerve trunks, sensory nerve endings, and neuromuscular junctions. Although LAs can block all kinds of nerves, the sensitivity of nerve fibers differs according to nerve types and structures. LAs are known to block myelinated fibers faster than unmyelinated ones. Also, they block pain or sensory neurons at low concentrations without affecting the motor neurons involved in muscle contractions. This helps relieve labor pain without affecting the...
879
Analgesia and Pain Management
668
Pain is critical to various clinical pathologies, provoking an urgent need for effective management. Pain, whether acute or chronic, is a complex neurochemical process. Its alleviation depends on the type, with nonopioid analgesics effective for mild to moderate pain, such as musculoskeletal or inflammatory pain, while neuropathic pain responds best to anticonvulsants, tricyclic antidepressants, or serotonin/norepinephrine reuptake inhibitors. For severe acute or chronic pain, opioids may be...
668
Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists
209
Neurokinin 1 (NK1) receptors are distributed across the GI tract, vagal afferents, and key CNS regions including the central vomiting center and chemoreceptor trigger zone (CTZ) Chemotherapy agents stimulate enterochromaffin cells in the gastrointestinal (GI) tract to release large amounts of substance P (SP). SP is a neuropeptide released by specific sensory nerves in response to many different stressors, including those in the GI mucosa affected by chemotherapy. SP binds and activates...
209
Nociception
28.0K
Nociception—the ability to feel pain—is essential for an organism’s survival and overall well-being. Noxious stimuli such as piercing pain from a sharp object, heat from an open flame, or contact with corrosive chemicals are first detected by sensory receptors, called nociceptors, located on nerve endings. Nociceptors express ion channels that convert noxious stimuli into electrical signals. When these signals reach the brain via sensory neurons, they are perceived as pain.
28.0K
Tumor Immunotherapy
575
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
575


